Artivion AORT
NYSE AORT
$22.29 +0.38 (+1.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artivion (AORT) Gains from Sales and Divestitures (2016 - 2025)

Updated

Artivion (AORT) reported Gains from Sales and Divestitures of $3.5 million for Q4 2025, unchanged from the prior quarter.

Analysis

Artivion (AORT) Gains from Sales and Divestitures (2016 - 2025) Analysis & Trends

For FY2025, Artivion posted Gains from Sales and Divestitures of $7 million.

  • Gains from Sales and Divestitures has a four-year compound annual growth rate of -18.6% (FY2021 to FY2025).
  • By year, Gains from Sales and Divestitures came in at $14.25 million in FY2023 and $15.92 million in FY2021.
  • Five-year quarterly Gains from Sales and Divestitures spans a low of $3.5 million in Q3 2025 and a high of $15.92 million in Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Artivion 1.09 Bn 815.36 Mn 80.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.50 Mn
Sep 30, 2025 3.50 Mn
Jun 30, 2023 14.25 Mn
Sep 30, 2021 15.92 Mn
Mar 31, 2016 7.92 Mn
API Access

Artivion Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AORT&period=max&api_key=YOUR_API_KEY